International Symposium on Compound Design Technologies

Of particular interest to computational chemists working in the pharmaceutical, biotechnology and drug discovery industries, attendees will hear about technologies that guide them to successful small molecule and biotherapeutic drug discovery and development, intuitive molecular design and 3D-QSAR interpretation as well as knowledge based toxicity prediction.

The keynote presentation will be made by Dr John Overington (EMBL-EBI) with other presentations from Dr. Kimito Funatsu (University of Tokyo), Dr. Yoshio Hamada (Kobe Gakuin University) and Dr. Hiroshi Chuman (University of Tokushima), Dr. Matt Segall (Optibrium), Dr. Tim Cheeseright (Cresset), Dr. Thierry Hanser (Lhasa Limited) and Dr. Mark Swindells (Chemogenomix).